Search research articles

Search research articles

Related Experiment Videos

Rhinitis and sleep apnea.

Maria T Staevska¹, Mariana A Mandajieva, Vasil D Dimitrov

¹Clinic of Asthma, Allergology, and Clinical Immunology, Medical University-Sofia, University Hospital Alexandrovska, Bulgaria. marista@rtb-mu.com

Current Allergy and Asthma Reports

|April 2, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trial.

The Lancet. Haematology·2026

Same author

Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry.

The World Allergy Organization journal·2021

Same author

A Three-Year Course of House Dust Mite Sublingual Immunotherapy Appears Effective in Controlling the Symptoms of Allergic Rhinitis.

American journal of rhinology & allergy·2018

Same author

Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticaria.

Therapeutics and clinical risk management·2016

Same author

Clinical characteristics of patients seeking medical advice for nasal symptoms in Bulgaria with special focus on children.

The World Allergy Organization journal·2016

Same author

Objective approach for fending off the sublingual immunotherapy placebo effect in subjects with pollenosis: double-blinded, placebo-controlled trial.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2014

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Rhinitis and nasal obstruction independently impact obstructive sleep apnea (OSA) severity and sleep quality. Treating nasal inflammation improves sleep, but nasal side effects can reduce adherence to nasal continuous positive airway pressure (nCPAP) therapy.

Area of Science:

Otolaryngology
Sleep Medicine
Respiratory Medicine

Background:

The upper airway, encompassing the nose and pharynx, functions as a continuum, establishing a biological link between rhinitis and obstructive sleep apnea (OSA).
Sleep-disordered breathing presents a broad differential diagnosis, including snoring, upper airway resistance syndrome, and severe OSA.
Nasal obstruction is recognized as an independent risk factor for OSA.

Purpose of the Study:

To explore the relationship between nasal conditions, specifically rhinitis and nasal obstruction, and their influence on obstructive sleep apnea (OSA).
To investigate the impact of nasal inflammation and resistance on sleep quality, daytime function, and treatment adherence in OSA patients.

Main Methods:

Review of existing literature on the interplay between nasal health and sleep-disordered breathing.

Related Experiment Videos

Analysis of studies examining nasal resistance, rhinitis severity, and their correlation with OSA parameters like the apnea-hypopnea index.

Evaluation of treatment outcomes for nasal inflammation and patient compliance with nasal continuous positive airway pressure (nCPAP) therapy.

Main Results:

While nasal obstruction is an independent OSA risk factor, daytime nasal resistance does not consistently correlate with OSA severity.
Nasal resistance independently predicts the apnea-hypopnea index in nonobese OSA patients.
Rhinitis is linked to mild OSA and frequently causes sleep fragmentation and microarousals; topical treatments improve sleep quality and reduce daytime symptoms.

Conclusions:

Nasal inflammation and obstruction significantly affect OSA and sleep quality.
Effective management of nasal conditions can improve sleep in OSA patients.
Adverse nasal effects associated with nCPAP therapy present a challenge to patient adherence.